Will procalcitonin reduce antibiotic use in intensive care?
Kollef
Marin H
MH
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO 63110, USA. mkollef@dom.wustl.edu
D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D016638:Critical Illness / Q000628:therapy*; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D011183:Postoperative Complications / Q000097:blood / Q000188:drug therapy*; D011498:Protein Precursors / Q000097:blood*
D000900:Anti-Bacterial Agents; D015415:Biomarkers; C000606589:CALCA protein, human; D011498:Protein Precursors; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide